It's safe to use in the long run, and research shows taking it for more than six years may even help protect your mental sharpness
It does not predict your response to GLP-Squared or determine your dose
The topline results showed that in adults with obesity or who are overweight and have type 2 diabetes, the drug provided significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors at 72 weeks
Quick Answer: Weight gain on tirzepatide is uncommon, as clinical trials show average weight losses of 1521%, but may occur due to medication non-adherence, concurrent weight-promoting drugs, fluid retention, dietary factors, or normal physiological fluctuations
We screen every patient at our Rockaway and Morristown locations for personal and family histories of thyroid C-cell tumors